Worldwide recognition for GLOBALHealthPR partners

The past few weeks have seen our GLOBALHealthPR partners receiving worldwide recognition for their fantastic work in Health + Wellness PR.

Last week, our agency, VIVA! Communications, was thrilled to clinch Australia’s ‘Best Public Health Initiative’ at the pharmaceutical industry’s annual PRIME Awards for our Enhancing Community Immunity Through Pharmacist-led Flu Vaccination campaign in partnership with the Pharmacy Guild of Australia.

VIVA! Communications is also very excited to announce our agency has been shortlisted for the NSW Small Agency of the Year in the 2018 PRIA Golden Target Awards. VIVA! is also contesting an award in the ‘Community Relations’ category, for our Enhancing Community Immunity Through Pharmacist-led Flu Vaccination campaign; and in the ‘Health’ category, we have been shortlisted for our Genetics of Depression study, conducted in partnership with the QIMR Berghofer.

Our US partner, Spectrum Science, also secured a significant win, with PR News announcing the agency as ‘Medium PR Firm of the Year’ at last week’s Platinum and Agency Elite luncheon in New York. A great accomplishment and a true testament to our best-in-class Spectrum partner.

Spectrum also won the ‘2018 Agency Elite Aware for Media Relations’ award for their Step Forward with Me campaign conducted in partnership with leading consumer genetics and research client, 23andMe.

Further to this, our Indian partner, MediaMedic Communications announced the shortlisting of their campaigns in the final five of the ‘Integrated’ and ‘Digital’ categories of the Big Bang Awards, demonstrating the diversity and strength of the GHPR skills-set.

Our UK partner, Aurora also announced they were contesting an award at the BMI Patient Information Awards this week for their work with Sanofi Genzyme.

We wish to send our best wishes and sincere congratulations to our fabulous GLOBALHealthPR partners, and look forward to hearing the outcomes of these award ceremonies and many more in due course.

There are no comments

Join the conversation

Your email address will not be published. Required fields are marked *